Home Bromides 200064-13-7
200064-13-7,MFCD11656285
Catalog No.:AA002CFO

200064-13-7 | 3-Bromo-5-morpholinopyridine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$9.00   $7.00
- +
250mg
98%
in stock  
$16.00   $11.00
- +
1g
98%
in stock  
$36.00   $25.00
- +
5g
98%
in stock  
$167.00   $117.00
- +
10g
95%
in stock  
$281.00   $197.00
- +
25g
95%
in stock  
$701.00   $491.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002CFO
Chemical Name:
3-Bromo-5-morpholinopyridine
CAS Number:
200064-13-7
Molecular Formula:
C9H11BrN2O
Molecular Weight:
243.1004
MDL Number:
MFCD11656285
SMILES:
Brc1cncc(c1)N1CCOCC1
Properties
Properties
 
Form:
Solid  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
162  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Rotatable Bond Count:
1  
XLogP3:
1.3  

Downstream Synthesis Route
110-91-8    625-92-3    200064-13-7   
4-(3-Bromo-pyridin-4-yl)-morpholine 
 
3,5-di-(4-morpholyl)pyridine 

[1]Vinter-Pasquier,Karine;Jamart-Gregoire,Brigitte;Caubere,Paul[Heterocycles,1997,vol.45,#11,p.2113-2129]

110-91-8    200064-13-7   
3,5-di-(4-morpholyl)pyridine 

[1]Vinter-Pasquier,Karine;Jamart-Gregoire,Brigitte;Caubere,Paul[Heterocycles,1997,vol.45,#11,p.2113-2129]

[1]Matulenko,MarkA.;Paight,ErnestS.;Frey,RobinR.;Gomtsyan,Arthur;DiDomenicoJr.,Stanley;Jiang,Meiqun;Lee,Chih-Hung;Stewart,AndrewO.;Yu,Haixia;Kohlhaas,KathyL.;Alexander,KarenM.;McGaraughty,Steve;Mikusa,Joseph;Marsh,KennanC.;Muchmore,StevenW.;Jakob,ClarissaL.;Kowaluk,ElizabethA.;Jarvis,MichaelF.;Bhagwat,ShripadS.[BioorganicandMedicinalChemistry,2007,vol.15,#4,p.1586-1605]

[1]Locationinpatent:experimentalpartBunnelle,WilliamH.;Tietje,KarinR.;Frost,JenniferM.;Peters,Dan;Ji,Anguo;Li,Tao;Scanio,MarcJ.C.;Shi,Lei;Anderson,DavidJ.;Dyhring,Tino;Grønlien,JensH.;Ween,Hilde;Thorin-Hagene,Kirsten;Meyer,MichaelD.[JournalofMedicinalChemistry,2009,vol.52,#14,p.4126-4141]

[2]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2013/267495,2013,A1Locationinpatent:Paragraph0438-0439

[3]Locationinpatent:experimentalpartDandu,ReddeppaReddy;Rose,AdamC.;Hudkins,RobertL.[Heterocycles,2011,vol.83,#4,p.875-881]

[4]Matulenko,MarkA.;Paight,ErnestS.;Frey,RobinR.;Gomtsyan,Arthur;DiDomenicoJr.,Stanley;Jiang,Meiqun;Lee,Chih-Hung;Stewart,AndrewO.;Yu,Haixia;Kohlhaas,KathyL.;Alexander,KarenM.;McGaraughty,Steve;Mikusa,Joseph;Marsh,KennanC.;Muchmore,StevenW.;Jakob,ClarissaL.;Kowaluk,ElizabethA.;Jarvis,MichaelF.;Bhagwat,ShripadS.[BioorganicandMedicinalChemistry,2007,vol.15,#4,p.1586-1605]

[5]CurrentPatentAssignee:HIBERCELLINC-WO2019/126730,2019,A1Locationinpatent:Paragraph0460

[6]Daili,Farah;Sengmany,Stéphane;Léonel,Eric[EuropeanJournalofOrganicChemistry,2021,vol.2021,#17,p.2462-2469]

[7]CurrentPatentAssignee:EPIZYME,INC.-WO2014/100716,2014,A1Locationinpatent:Paragraph00230

[8]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2011/75559,2011,A1Locationinpatent:Page/Pagecolumn61;62

[9]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-US2014/323468,2014,A1Locationinpatent:Paragraph0542

[1]Matulenko,MarkA.;Paight,ErnestS.;Frey,RobinR.;Gomtsyan,Arthur;DiDomenicoJr.,Stanley;Jiang,Meiqun;Lee,Chih-Hung;Stewart,AndrewO.;Yu,Haixia;Kohlhaas,KathyL.;Alexander,KarenM.;McGaraughty,Steve;Mikusa,Joseph;Marsh,KennanC.;Muchmore,StevenW.;Jakob,ClarissaL.;Kowaluk,ElizabethA.;Jarvis,MichaelF.;Bhagwat,ShripadS.[BioorganicandMedicinalChemistry,2007,vol.15,#4,p.1586-1605]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:200064-13-7 Molecular Formula|200064-13-7 MDL|200064-13-7 SMILES|200064-13-7 3-Bromo-5-morpholinopyridine